Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64


Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.

Foks AC, Kuiper J.

Br J Pharmacol. 2017 Nov;174(22):3940-3955. doi: 10.1111/bph.13802. Epub 2017 May 4. Review.


Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.

Sage AP, Mallat Z.

Br J Pharmacol. 2017 Nov;174(22):3926-3939. doi: 10.1111/bph.13700. Epub 2017 Feb 1. Review.


The Roles of CD137 Signaling in Atherosclerosis.

Jung IH, Oh GT.

Korean Circ J. 2016 Nov;46(6):753-761. Epub 2016 Oct 20. Review.


Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFN╬│+ Th1/Tregs.

Butcher MJ, Filipowicz AR, Waseem TC, McGary CM, Crow KJ, Magilnick N, Boldin M, Lundberg PS, Galkina EV.

Circ Res. 2016 Nov 11;119(11):1190-1203. doi: 10.1161/CIRCRESAHA.116.309764. Epub 2016 Sep 15.


Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis.

Cheng HY, Gaddis DE, Wu R, McSkimming C, Haynes LD, Taylor AM, McNamara CA, Sorci-Thomas M, Hedrick CC.

J Clin Invest. 2016 Sep 1;126(9):3236-46. doi: 10.1172/JCI83136. Epub 2016 Aug 2.


Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Allen S, Liu YG, Scott E.

Regen Eng Transl Med. 2016 Mar;2(1):37-50. Epub 2016 Mar 3.


CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis.

Li J, McArdle S, Gholami A, Kimura T, Wolf D, Gerhardt T, Miller J, Weber C, Ley K.

Circ Res. 2016 May 13;118(10):1540-52. doi: 10.1161/CIRCRESAHA.116.308648. Epub 2016 Mar 28.


Microdomains, Inflammation, and Atherosclerosis.

Sorci-Thomas MG, Thomas MJ.

Circ Res. 2016 Feb 19;118(4):679-91. doi: 10.1161/CIRCRESAHA.115.306246. Review.


2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis.

Ley K.

Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):429-38. doi: 10.1161/ATVBAHA.115.306009. Epub 2016 Jan 28.


The Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection.

Wikenheiser DJ, Ghosh D, Kennedy B, Stumhofer JS.

J Immunol. 2016 Jan 15;196(2):778-91. doi: 10.4049/jimmunol.1403206. Epub 2015 Dec 14.


Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals.

Zhu R, Liu C, Tang H, Zeng Q, Wang X, Zhu Z, Liu Y, Mao X, Zhong Y.

Mediators Inflamm. 2015;2015:457167. doi: 10.1155/2015/457167. Epub 2015 Nov 18.


The reduced soluble fibrinogen-like protein 2 and regulatory T cells in acute coronary syndrome.

Liu K, Li T, Huang S, Long R, You Y, Liu J, Wang Z.

Exp Biol Med (Maywood). 2016 Feb;241(4):421-5. doi: 10.1177/1535370215612138. Epub 2015 Oct 28.


Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research.

Sawyer DM, Amenta PS, Medel R, Dumont AS.

Mediators Inflamm. 2015;2015:896283. doi: 10.1155/2015/896283. Epub 2015 Apr 1. Review.


Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance.

Yang S, Fujikado N, Kolodin D, Benoist C, Mathis D.

Science. 2015 May 1;348(6234):589-94. doi: 10.1126/science.aaa7017. Epub 2015 Mar 19.


Lymphocytes in atherosclerosis.

Hedrick CC.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):253-7. doi: 10.1161/ATVBAHA.114.305144. Review. No abstract available.


Treating atherosclerosis with regulatory T cells.

Foks AC, Lichtman AH, Kuiper J.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):280-7. doi: 10.1161/ATVBAHA.114.303568. Epub 2014 Nov 20. Review.


T cells in vascular inflammatory diseases.

Lintermans LL, Stegeman CA, Heeringa P, Abdulahad WH.

Front Immunol. 2014 Oct 14;5:504. doi: 10.3389/fimmu.2014.00504. eCollection 2014. Review.


Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells.

Sakthivel P, Gereke M, Breithaupt A, Fuchs D, Gigliotti L, Gruber AD, Dianzani U, Bruder D.

PLoS One. 2014 Jul 16;9(7):e100970. doi: 10.1371/journal.pone.0100970. eCollection 2014.


Distinct functions of specialized dendritic cell subsets in atherosclerosis and the road ahead.

Zernecke A.

Scientifica (Cairo). 2014;2014:952625. doi: 10.1155/2014/952625. Epub 2014 Apr 10. Review.


CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response.

Kasahara K, Sasaki N, Yamashita T, Kita T, Yodoi K, Sasaki Y, Takeda M, Hirata K.

J Am Heart Assoc. 2014 Apr 22;3(2):e000719. doi: 10.1161/JAHA.113.000719. Erratum in: J Am Heart Assoc. 2015 Mar;4(3):e000750.

Supplemental Content

Support Center